(MedPage Today) -- A specific genetic variant in rheumatoid arthritis patients contributes to high levels of a pathogenic biomarker that is associated with more progressive disease and poorer response to treatment, researchers have found.
via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment